{"id":"W2891596347","doi":"10.1186/s13045-018-0661-x","title":"A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis","year":2018,"lang":"en","type":"letter","venue":"Journal of Hematology & Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"Fondazione Regionale per la Ricerca Biomedica; F. Hoffmann-La Roche","keywords":"Ruxolitinib; Vismodegib; Myelofibrosis; Medicine; Internal medicine; Hematology; Oncology; Phases of clinical research; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007595635,0.000407035,0.002339623,0.0007562899,0.00006238073,0.00001345481,0.0002104433,0.0004302111,0.00005386168],"category_scores_gemma":[0.0003930008,0.0001997373,0.00007026058,0.0003423569,0.0003547347,0.00008385293,0.00009034917,0.001469045,0.000002998136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004009659,"about_ca_system_score_gemma":0.0006423596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001003591,"about_ca_topic_score_gemma":0.0008322087,"domain_scores_codex":[0.9963642,0.001012382,0.001350045,0.0003992319,0.0004837449,0.0003903623],"domain_scores_gemma":[0.9950526,0.002236748,0.001631882,0.0003147923,0.0006457607,0.0001182704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03984198,0.01885743,0.9164981,0.000169685,0.001148537,0.00337674,0.003719836,0.000005329461,0.0000022401,0.00003595361,0.01428422,0.002060007],"study_design_scores_gemma":[0.0908521,0.1439946,0.7569203,0.001277225,0.00104755,0.0007827032,0.0006078394,0.000005574132,0.0001095531,0.00003193755,0.004162206,0.000208451],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9416677,0.00005890275,0.00003754034,0.05561579,0.0002070036,0.00233005,0.00003246588,0.000004926374,0.00004565642],"genre_scores_gemma":[0.9795716,0.00008881878,0.0008286944,0.01906456,0.0002035565,0.0001306605,0.00004719149,0.00004452698,0.00002039369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1595778,"threshold_uncertainty_score":0.814505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02247277291908018,"score_gpt":0.331314420234806,"score_spread":0.3088416473157258,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}